CLINICAL CHARACTERISTICS OF PATIENTS WITH URETHRAL AND VAGINAL DISCHARGE SYNDROME AT HANOI DERMATOLOGY HOSPITAL IN 2025 AND SOME RELATED FACTORS

Thị Chi Phương Lê, Xuân Hương Vũ, Thị Thanh Hương Phạm, Thị Liên Hương Nguyễn

Main Article Content

Abstract

Objective: Describe the clinical characteristics of patients with urethral and vaginal discharge syndrome at Hanoi Dermatology Hospital in 2025 and some related factors. Subjects and methods: Descriptive, cross-sectional study on 125 patients with urethral or vaginal discharge syndrome tested for 12 sexually transmitted pathogens at Hanoi Dermatology Hospital in 2025. Results: The study was conducted on 125 patients with urethral and vaginal discharge syndrome, of which 54 cases (43,2%) were positive for at least one sexually transmitted pathogen. The 20–29 age group had the highest proportion (46,4%), with more men than women (47,3% vs 44,1%). Multivariate regression analysis showed that large discharge (OR = 3,14; 95% CI: 1,06–6,54), cloudy discharge (OR = 5,56; 95% CI: 1,73–17,90), functional symptoms (OR = 2,27; 95% CI: 1,58–8,25), and clinical signs of inflammation (OR = 3,41; 95% CI: 1,27–7,35) were all statistically significantly associated with positive results. In contrast, a history of recent antibiotic use reduced the odds of detecting the agent (OR = 0,30; 95% CI: 0,06–0,87). Conclusion: Clinical features, especially the nature of the discharge and signs of inflammation, are valuable in predicting the likelihood of STD positivity in patients with the discharge syndrome. Previous antibiotic use reduced the likelihood of detection.

Article Details

References

1. WHO. Global Health Sector Strategy on Sexually Transmitted Infections 2016–2021. Geneva: World Health Organization; 2016.
2. Mhlongo S, Magooa P, Müller EE, et al. Etiology and STI/HIV coinfections among patients with urethral and vaginal discharge syndromes in South Africa. Sex Transm Dis. 2010;37(9):566–70.
3. Lewis DA. The diagnosis of urethritis and cervicitis: an update. Clin Infect Dis. 2011;53 Suppl 3:S214–22.
4. Rawre J, Juyal D, Dhawan B. Urethritis and cervicitis: current etiological trends from India. Indian J Med Res. 2016;144(4):503–10.
5. Mlisana K, Naicker N, Werner L, et al. Symptomatic vaginal discharge is a poor predictor of sexually transmitted infections and genital tract inflammation in high-risk women in South Africa. J Infect Dis. 2012;206(1):6–14.
6. Nguyễn Khắc Cường, Đặng Văn Em. Đặc điểm lâm sàng và căn nguyên hội chứng tiết dịch sinh dục tại Việt Nam. Tạp chí Da liễu Việt Nam. 2018;28(4):12–18.
7. Centers for Disease Control and Prevention (CDC). Sexually transmitted infections treatment guidelines, 2021. MMWR Recomm Rep. 2021;70(4):1–187.
8. Dukers-Muijrers NHTM, van Liere GAFS, Hoebe CJPA, et al. Antibiotic use before chlamydia and gonorrhea testing in STI clinics: impact on test outcomes. Antimicrob Agents Chemother. 2015;59(9):5832–39.